Jan Reed - Stepan Independent Director
| SCL Stock | USD 63.37 0.90 1.44% |
Director
Ms. Jan Stern Reed serves as Independent Director of Stepan Company. Ms. Reed is the former Senior Vice President, General Counsel and Corporationrationrate Secretary of Walgreens Boots Alliance, Inc., a global pharmacyled, health and wellbeing enterprise, as well as the former Senior Vice President, General Counsel and Secretary of Walgreen Co. Prior to Walgreens, Ms. Reed was the Executive Vice President of Human Resources, General Counsel and Secretary of Solo Cup Company. Ms. Reed also serves as a director for AngioDynamics, Inc since 2015.
| Age | 61 |
| Tenure | 10 years |
| Address | 1101 Skokie Boulevard, Northbrook, IL, United States, 60062 |
| Phone | 847 446 7500 |
| Web | https://www.stepan.com |
Stepan Management Efficiency
The company has Return on Asset of 0.0201 % which means that on every $100 spent on assets, it made $0.0201 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0422 %, implying that it generated $0.0422 on every 100 dollars invested. Stepan's management efficiency ratios could be used to measure how well Stepan manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.02. The value of Return On Capital Employed is expected to slide to 0.04. At this time, Stepan's Intangibles To Total Assets are quite stable compared to the past year. Fixed Asset Turnover is expected to rise to 2.76 this year, although the value of Other Assets will most likely fall to 1.09.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Paul Suckow | Oil Dri | 73 | |
| John Roden | H B Fuller | 70 | |
| Melissa McClain | Quaker Chemical | N/A | |
| Sharad Jain | Sensient Technologies | 61 | |
| Edward Cichurski | Sensient Technologies | 79 | |
| Mark Douglas | Quaker Chemical | 58 | |
| Alison Deans | Minerals Technologies | 59 | |
| Donald Caldwell | Quaker Chemical | 74 | |
| Steven Williams | Innospec | 69 | |
| Robert Rock | Quaker Chemical | 70 | |
| Donald Winter | Minerals Technologies | 72 | |
| Sanjay Hinduja | Quaker Chemical | 56 | |
| John Carmola | Minerals Technologies | 65 | |
| Charlotte Decker | Quaker Chemical | 56 | |
| Michael Nemeroff | Oil Dri | 57 | |
| Joseph Breunig | Minerals Technologies | 59 | |
| Fay West | Quaker Chemical | 52 | |
| Robert Clark | Minerals Technologies | 57 | |
| Neil Green | Avient Corp | 51 | |
| Daniel Florness | H B Fuller | 57 | |
| Franklin Feder | Minerals Technologies | 70 | |
Management Performance
| Return On Equity | 0.0422 | ||||
| Return On Asset | 0.0201 |
Stepan Company Leadership Team
Elected by the shareholders, the Stepan's board of directors comprises two types of representatives: Stepan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stepan. The board's role is to monitor Stepan's management team and ensure that shareholders' interests are well served. Stepan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stepan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arthur Mergner, Vice President General Manager - Polymers | ||
| Luis Rojo, Chief Financial Officer, Vice President, IR Contact Officer | ||
| Matthew Eaken, Interim CFO, Vice President Corporate Controller | ||
| Jason Keiper, Vice President and Chief Technology and Sustainability Officer | ||
| Frank Stepan, Chairman of the Board, President, Chief Executive Officer | ||
| Janet Catlett, Chief Human Resource Officer, Vice President | ||
| Mark Mydlach, Vice Sales | ||
| Jan Reed, Independent Director | ||
| Sharon Purnell, Vice Officer | ||
| Lorinda Burgess, Independent Director | ||
| David Mattingly, VP Officer | ||
| Michael Boyce, Independent Director | ||
| Gregory Lawton, Independent Director | ||
| Scott Behrens, Vice President, General Manager - Surfactants | ||
| Matthew Rice, Assistant Secretary | ||
| Samuel Hinrichsen, Interim VP | ||
| Debra Stefaniak, Vice President- Business Transformation | ||
| Richard Stepan, Vice President General Manager - Polymers | ||
| Robert Haire, Executive Chain | ||
| Edward Wehmer, Lead Independent Director | ||
| John Venegoni, Consultant | ||
| Joaquin Delgado, Independent Director | ||
| Randall Dearth, Independent Director | ||
| David Kabbes, Vice President General Counsel, Secretary | ||
| Sean Moriarty, Vice President, General Manager - Surfactants | ||
| David David, Vice President General Counsel, Secretary |
Stepan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Stepan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0422 | ||||
| Return On Asset | 0.0201 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 2 B | ||||
| Shares Outstanding | 22.49 M | ||||
| Shares Owned By Insiders | 3.77 % | ||||
| Shares Owned By Institutions | 86.21 % | ||||
| Number Of Shares Shorted | 408.63 K | ||||
| Price To Earning | 18.38 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Stepan Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stepan. If investors know Stepan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stepan listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Dividend Share 1.51 | Earnings Share 2.2 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
The market value of Stepan Company is measured differently than its book value, which is the value of Stepan that is recorded on the company's balance sheet. Investors also form their own opinion of Stepan's value that differs from its market value or its book value, called intrinsic value, which is Stepan's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stepan's market value can be influenced by many factors that don't directly affect Stepan's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stepan's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stepan is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stepan's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.